Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
University of Heidelberg Medical Center
Sunnybrook Health Sciences Centre
Northwestern University
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Baylor College of Medicine
Baylor College of Medicine
Mayo Clinic
New York Medical College
University of North Carolina, Chapel Hill
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Hospices Civils de Lyon
Alliance for Clinical Trials in Oncology
Asan Medical Center
Vanderbilt-Ingram Cancer Center
Cancer Research UK
Case Comprehensive Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of California, San Francisco